Search - tctmd.com

Presenter: Joseph Kim, Helen Vlachos, Suresh R. Mulukutla, Catalin Toma, Joon S. Lee, David O. Williams, Sheryl F. Kelsey, Kevin E. Kip, Oscar C. Marroquin

January 03, 2012

Presentation TCT 2012

Benefits of CD 34 Antibody Coated Stent in Patients with High Risk for Bleeding During Dual Antiplatelet Therapy.

Presenter: Miltiadis Papalexandris, Hubertus Degen, Carsten Stoepel, Thomas Lickfeld, Thorsten Schneider, Carlos Freitas, Michael Haude

January 03, 2012

Presentation TCT 2012

”Safety of Dual Antiplatelet Therapy in Patients Treated with Coronary Drug Eluting Stents.”

Presenter: Andrzej Drewnicki, Maciej Lesiak, Malgorzata Pyda, Marek Grygier, Wlodzimierz Skorupski, Aleksander Araszkiewicz, Przemyslaw Mitkowski, Stefan Grajek

January 03, 2012

News Daily News

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

December 04, 2011

Advertisement

Surgery Common, Safe After Coronary Stent Implantation

TCTMD’s Top 10 Most Popular News Stories From 2011

Meta-Analysis: Adjunctive Cilostazol Lowers Repeat Revascularization After PCI

Stent Thrombosis Risk Lower with Xience vs. First-Generation DES

Restenotic Pattern After Femoropopliteal Stenting Predicts Recurrence

PEPCAD-DES: Paclitaxel-Coated Balloon Bests Plain Balloon for DES Restenosis

Meta-Analysis: Mixed Results Seen with First-Gen DES in STEMI Patients

EVOLVE Published: Bioabsorbable EES Matches Permanent-Polymer Version

Interventional Issues Featured in AHA/ASA ‘Top 10’ Research Reports of 2011

Similar Mortality Rates Seen in Men and Women with NSTE ACS

PROFI Published: Better Cerebral Protection with Balloon Occlusion after CAS

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

The Value of Dual Antiplatelet Therapy During and After Endovascular Procedures: Results of a Randomized Trial - The MIRROR Study

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

SCAAR: Second-Generation DES Improve Hard Outcomes

DES Show Better Outcomes vs. BMS in Elderly, Though Use Declining

Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients with Chronic Kidney Disease: A Report From the National Heart, Lung, and Blood...

Benefits of CD 34 Antibody Coated Stent in Patients with High Risk for Bleeding During Dual Antiplatelet Therapy.

”Safety of Dual Antiplatelet Therapy in Patients Treated with Coronary Drug Eluting Stents.”

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content